Identifying New Genetic Causes to Development Disorders
Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Sep 13, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand the genetic causes behind certain growth and development disorders, such as problems with puberty and sex development. Researchers will use a technique called exome analysis, which helps identify new genetic mutations that could be responsible for these issues. By participating, the trial aims to uncover how common these mutations are and whether they relate to other health problems.
If you or someone you know has conditions like congenital growth hormone deficiency, puberty disorders, or disorders of sex development, you might be eligible to join the study. Family members of patients with these conditions can also participate. The trial is currently recruiting participants of all ages and genders. Those who take part will help researchers learn more about these disorders, which could lead to better understanding and treatment options in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • congenital growth hormone deficiency
- • puberty disorder
- • gonadal dysgenesis or anorchia
- • primary ovarian failure
- • disorder of sex development
- • subjects related to a patient with one of the above criteria
- Exclusion Criteria:
- • environmental or auto-immune cause
About Fondation Ophtalmologique Adolphe De Rothschild
The Fondation Ophtalmologique Adolphe de Rothschild is a leading French institution dedicated to advancing ophthalmic research and patient care. Renowned for its commitment to innovation in eye health, the foundation conducts cutting-edge clinical trials aimed at improving treatments for various ocular conditions. With a multidisciplinary team of experts, the foundation collaborates with academic and industry partners to enhance understanding of eye diseases and develop novel therapeutic solutions, ultimately striving to improve patient outcomes and quality of life in ophthalmology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Raja Brauner, PU-PH
Principal Investigator
Hôpital Fondation A. de Rothschild
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials